Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Dansette

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Biochemical Pharmacology|February 15, 1991
Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylationP M Dansette, C Amar, P Valadon, et al.
Clinical Pharmacology and Therapeutics|February 1, 1977
Hydration of arene and alkene oxides by epoxide hydrase in human liver microsomesJ Kapitulnik, W Levin, R Morecki, et al.
Biochemical and Biophysical Research Communications|January 5, 1996
Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase BC Pons, P M Dansette, J Gregeois, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1976
Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skinW Levin, A W Wood, H Yagi, et al.
Journal of Medicinal Chemistry|October 19, 2001
Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamilyN T Ha-Duong, S Dijols, C Marques-Soares, et al.
Biochemistry|October 3, 2001
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19N T Ha-Duong, S Dijols, A C Macherey, et al.
Archives of Biochemistry and Biophysics|October 12, 2001
Interaction of new sulfaphenazole derivatives with human liver cytochrome p450 2Cs: structural determinants required for selective recognition by CYP 2C9 and for inhibition of human CYP 2CsN T Ha-Duong, C Marques-Soares, S Dijols, et al.
European Journal of Biochemistry|April 1, 1993
Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10M P Lopez Garcia, P M Dansette, P Valadon, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11C Pons, P M Dansette, C Amar, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1987
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drugP Beaune, P M Dansette, D Mansuy, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|February 15, 1991
Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylationP M Dansette, C Amar, P Valadon, et al.
Clinical Pharmacology and Therapeutics|February 1, 1977
Hydration of arene and alkene oxides by epoxide hydrase in human liver microsomesJ Kapitulnik, W Levin, R Morecki, et al.
Biochemical and Biophysical Research Communications|January 5, 1996
Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase BC Pons, P M Dansette, J Gregeois, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1976
Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skinW Levin, A W Wood, H Yagi, et al.
Journal of Medicinal Chemistry|October 19, 2001
Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamilyN T Ha-Duong, S Dijols, C Marques-Soares, et al.
Biochemistry|October 3, 2001
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19N T Ha-Duong, S Dijols, A C Macherey, et al.
Archives of Biochemistry and Biophysics|October 12, 2001
Interaction of new sulfaphenazole derivatives with human liver cytochrome p450 2Cs: structural determinants required for selective recognition by CYP 2C9 and for inhibition of human CYP 2CsN T Ha-Duong, C Marques-Soares, S Dijols, et al.
European Journal of Biochemistry|April 1, 1993
Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10M P Lopez Garcia, P M Dansette, P Valadon, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11C Pons, P M Dansette, C Amar, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1987
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drugP Beaune, P M Dansette, D Mansuy, et al.
Pageof 7